Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Hold
8,490
2.19% 23
2026
Q1
$2.99M Hold
8,490
2.03% 22
2025
Q4
$2.78M Hold
8,490
2.07% 17
2025
Q3
$2.4M Hold
8,490
1.94% 20
2025
Q2
$2.37M Hold
8,490
2.18% 17
2025
Q1
$2.65M Buy
+8,490
New +$2.51M 2.64% 12
2024
Q3
$2.74M Hold
8,490
2.55% 15
2024
Q2
$2.65M Hold
8,490
2.58% 13
2024
Q1
$2.41M Hold
8,490
2.26% 16
2023
Q4
$2.44M Hold
8,490
2.49% 16
2023
Q3
$2.28M Hold
8,490
2.45% 16
2023
Q2
$1.89M Hold
8,490
2.01% 24
2023
Q1
$2.05M Hold
8,490
2.07% 20
2022
Q4
$2.23M Hold
8,490
2.47% 12
2022
Q3
$1.91M Buy
+8,490
New +$2.06M 2.3% 17
2022
Q1
$1.93M Hold
8,490
1.94% 21
2021
Q4
$1.91M Hold
8,490
1.92% 20
2021
Q3
$1.8M Hold
8,490
1.92% 19
2021
Q2
$2.07M Hold
8,490
2.06% 20
2021
Q1
$2.11M Hold
8,490
2.35% 15
2020
Q4
$1.95M Hold
8,490
2.33% 16
2020
Q3
$2.16M Hold
8,490
3% 7
2020
Q2
$2M Hold
8,490
2.66% 14
2020
Q1
$1.72M Hold
8,490
2.33% 19
2019
Q4
$2.05M Hold
8,490
1.96% 26
2019
Q3
$1.64M Hold
8,490
1.57% 32
2019
Q2
$1.56M Hold
8,490
1.38% 32
2019
Q1
$1.61M Hold
8,490
1.38% 32
2018
Q4
$1.65M Buy
8,490
+74
+0.9% +$14.4K 1.41% 32
2018
Q3
$1.75M Hold
8,416
1.31% 33
2018
Q2
$1.55M Hold
8,416
1.14% 33
2018
Q1
$1.44M Buy
+8,416
New +$1.54M 1.13% 32

Other funds holding AMGN

Lesa Sroufe & Co's AMGN Position: Q2 2026 in Review

Lesa Sroufe & Co held its Amgen (AMGN) position steady in Q2 2026 at 8,490 shares worth $3.07M. The position accounts for 2.19% of the portfolio, ranked #23.

Lesa Sroufe & Co first reported a position in AMGN in Q1 2018 and has held it in 32 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lesa Sroufe & Co held 8,490 shares of Amgen worth $3.07M as of Q2 2026.
  • Lesa Sroufe & Co left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 2.19% of Lesa Sroufe & Co's portfolio in Q2 2026, its #23 holding.
  • Lesa Sroufe & Co first reported a position in Amgen in Q1 2018 and has held it in 32 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lesa Sroufe & Co's 13F filing for Q2 2026, filed 22 Jul 2026.